Clear.bio

Clear.bio

Private
AmsterdamHealthcare & Life Scienceshttps://clear.bio

Last Round

VC Round

Sep 25, 2025

Momentum Score

50 /100

Company Overview

Clear.bio is a healthtech company that provides a digital therapeutics platform with personalized nutrition plans to help users manage type 2 diabetes.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Telemedicine, Medical AI, Health IoT, Medical Devices

Business Model

B2C

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

digital therapeuticsDTxdiabetes managementcontinuous glucose monitoringCGMpersonalized nutritionmetabolic healthglycemic controldigital healthwearable sensorhealth coachingAI healthtechhealth insurance reimbursementmedical deviceketenzorg

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Clear.bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Clear.bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 25, 2025
VC RoundNov 9, 2022
VC RoundMar 10, 2022
VC RoundNov 3, 2021

Key People

Founding team and executive leadership

Piet Hein van Dam

CEO And Founder

Founding Team

Parul Vats

Chief Technology Officer

Executive Team

Clear.bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 25, 2025

    $1.84M round raised.

  • Mar 30, 2025

    Added Cliquemedia, a digital media SMB, as a customer.

Clear.bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Clear.bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Clear.bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmsterdam
Employee Range22
Year Founded2019
Last FundingSep 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.